Academic and Commercial Institutions Team Up to Enrich Variant Analysis


In a move that directly addresses the problems plaguing the ability to conduct statistically-driven analysis of clinical genomic data (as described in the previous post), Qiagen and LabCorp have teamed up with multiple prestigious academic institutions to form the Allele Frequency Community.

This group will pool its anonymized genomic data to allow for better power in interpreting variations of unknown significance. It describes itself as a “freely accessible “opt-in” community resource designed to facilitate sharing of anonymized, pooled allele frequency statistics among laboratories for the benefit of patients and biomedical research.”

Collaborations such as this must surely be the only way that sufficient amounts of data can inform clinical decision-making in a whole genome sequencing world.

Press release.


Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access